(Q33705837)

28 July 2017

1 reference

title

Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? (English)

1 reference

28 July 2017

1 reference

Morton DL

1

1 reference

28 July 2017

Chan AD

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Journal of the American College of Surgeons

28 July 2017

published in

1 reference

28 July 2017

volume

189

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

214-223

1 reference

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Malignant melanoma: Mayo Clinic experience

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Surgical management of malignant melanoma of the trunk and extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Groin dissection in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Lymphatic drainage of skin to a sentinel lymph node in a feline model.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Management of the regional lymph nodes in patients with cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Lymphatic mapping and sentinel lymphadenectomy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Improved axillary staging of breast cancer with sentinel lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Minimal-access surgery for staging of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

A rational approach to the surgical management of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Whole-body lymphangioscintigraphy: preferred method for initial assessment of the peripheral lymphatic system

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Quantitative lymphoscintigraphy using 99Tcm human serum albumin in patients with previously treated uterine cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Technetium-99M Sulfide Colloid Preparation for Scintigraphy of the Reticuloendothelial System

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Gamma-probe-guided lymph node localization in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Sentinel lymphadenectomy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Sentinel lymphadenectomy in thyroid malignant neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

S100 protein: a marker for human malignant melanomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with s-100 protein in paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

S-100 protein remains a practical marker for melanocytic and other tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Optimal selective sentinel lymph node dissection in primary malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Primary therapy of malignant melanomas: sentinel lymphadenectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Lymphatic mapping and sentinel node harvest for malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Intraoperative lymphatic mapping for early-stage melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Metastasis of primary melanoma to two separate lymph node basins: prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Localization and resection of an in transit sentinel lymph node by use of lymphoscintigraphy, intraoperative lymphatic mapping, and a hand-held gamma probe

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Detection of beta-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Detection of Submicroscopic Lymph Node Metastases in Patients With Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Lymphatic mapping and sentinel lymphadenectomy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Sentinel lymphadenectomy for patients with clinical stage I melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

The orderly progression of melanoma nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Intraoperative identification of sentinel lymph node in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2899%2900129-5

7 January 2021

10.1016/S1072-7515(99)00129-5

Identifiers

DOI

1 reference

28 July 2017

1 reference